Patrik Jeanmonod, Chief Financial Officer at Cytek Biosciences, Inc. (CTKB), sold 3,500 shares at $14.30 ($50K) on 2022-11-25, disclosed to the SEC on 2022-11-28.
Open-market sale of $50k CTKB by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CTKB | SELL | 2023-10-25 | $14K | — | Filing → |
| CTKB | SELL | 2023-09-26 | $19K | — | Filing → |
| CTKB | SELL | 2023-08-28 | $23K | — | Filing → |